NCT02570633View on ClinicalTrials.gov

Ginger Capsules for the Prophylactic Treatment of Migraine

NACompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

November 30, 2016

Conditions
Migraine
Interventions
OTHER

Extract of ginger

Migraine patients (both genders) will receive capsules of 200 mg of ginger extract (5% gingerols) to be taken three times a day for 12 weeks.

OTHER

Cellulose

Migraine patients (both genders) will receive capsules of 200 mg of placebo (cellulose) to be taken three times a day for 12 weeks.

Trial Locations (1)

30130-100

Ambulatório Bias Fortes, Belo Horizonte

All Listed Sponsors
lead

Federal University of Minas Gerais

OTHER

NCT02570633 - Ginger Capsules for the Prophylactic Treatment of Migraine | Biotech Hunter | Biotech Hunter